Contact Us

Yes. SNAT5 rescue experiments require attention to pH-dependence and sodium coupling: • Construct design: use a codon-modified SLC38A5 sequence with a small C-terminal tag (FLAG, HA). The 11 transmembrane SLC38 architecture must be preserved. • Transport-deficient rescue: substrate-binding pocket or sodium-binding residue mutations enable structure-function studies. • pH-dependent activity studies: SNAT5 transport is pH-sensitive; rescue lines should be characterized under defined pH conditions for consistent functional readouts. • Functional readout: rescue should restore sodium-dependent glutamine and asparagine uptake measured by radiolabel or LC-MS. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC4A3 (AE3)'s role in chloride-bicarbonate exchange or its specific functions in cardiac and neuronal pH regulation. The Knockout line is appropriate for asking whether AE3 is required for chloride/bicarbonate exchange in colorectal cancer contexts. Overexpression is useful for studying cardiac (cAE3) versus brain (bAE3) splice variants or for testing transport activity. For anion exchanger research, the EDITGENE SLC4A3 Knockout in HCT 116 provides a colorectal cancer-relevant context, though AE3's principal physiological sites are heart and brain. SLC4A3 variants have been associated with idiopathic generalized epilepsy susceptibility. Rescue with wild-type, splice variant-specific, or transport-deficient AE3 enables structure-function studies.

Yes. AE3 rescue experiments require attention to splice variant and tissue-specific biology: • Construct design: use a codon-modified SLC4A3 sequence with a small C-terminal tag (FLAG, HA). The 14 transmembrane SLC4 architecture must be preserved. • Splice variant rescue: cAE3 (cardiac) and bAE3 (brain) variants have distinct N-termini; separate rescue with each variant enables isoform-specific functional studies. • Transport-deficient rescue: substrate-binding mutations or specific stilbene disulfonate-binding residue mutations enable mechanistic dissection. • Functional readout: rescue should restore chloride-bicarbonate exchange activity measured by intracellular pH and chloride imaging. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC6A6 (TauT)'s role in taurine transport or its emerging functions in osmoregulation and antioxidant homeostasis. The Knockout line is the standard tool for asking whether SLC6A6 is required for taurine uptake — TauT is the principal sodium-dependent taurine transporter expressed in many tissues including intestinal epithelium. Overexpression is useful for transport kinetics studies and for assessing inhibitor specificity. For taurine biology research, the EDITGENE SLC6A6 Knockout in HCT 116 is relevant for studying intestinal taurine handling and the emerging role of taurine in colorectal cancer biology. TauT mutations cause autosomal recessive retinal degeneration — disease variant rescue enables genotype-function studies. Rescue with wild-type or transport-deficient TauT is the standard specificity control.

Yes. TauT rescue experiments require attention to membrane topology and substrate recognition: • Construct design: use a codon-modified SLC6A6 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane SLC6 family architecture must be preserved. • Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing transport from non-transport functions. • Disease mutation rescue: retinal degeneration-associated SLC6A6 variants enable disease genotype-function correlation studies. • Functional readout: rescue should restore ³H-taurine uptake activity and downstream phenotypes related to taurine-dependent processes. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC25A37 (mitoferrin-1)'s role in mitochondrial iron import or its contributions to heme and iron-sulfur cluster biosynthesis. The Knockout line is the standard tool for asking whether mitoferrin-1 is required for delivering iron into the mitochondrial matrix — mitoferrin-1 is the principal mitochondrial iron importer in erythroid cells, with mitoferrin-2 (SLC25A28) playing a complementary role in non-erythroid tissues. Overexpression is useful for studying mitochondrial iron uptake mechanism or for rescue experiments. For mitochondrial iron biology research, the EDITGENE Mitoferrin-1 Knockout in HCT 116 enables study of mitochondrial iron import and downstream Fe-S cluster and heme biosynthesis. Mitoferrin-2 expression analysis is important given functional overlap in non-erythroid contexts. Rescue with wild-type or transport-deficient mitoferrin-1 is the standard specificity control. The knockout is relevant for studying erythroid maturation defects and iron metabolism in cancer biology.

Yes. Mitoferrin-1 rescue experiments require attention to mitochondrial inner membrane targeting: • Construct design: use a codon-modified SLC25A37 sequence with a small C-terminal tag (FLAG, HA). Mitoferrin-1 has the canonical SLC25 family 6-transmembrane architecture with mitochondrial targeting determinants. • Mitochondrial localization validation: confirm mitochondrial inner membrane localization by immunofluorescence co-staining with mitochondrial markers (TOM20, ATP5A) before functional assays. • Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies. • Functional readout: rescue should restore mitochondrial iron uptake, heme biosynthesis (protoporphyrin IX clearance), and Fe-S cluster-dependent enzyme activities. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC41A1's role as a Mg²⁺ efflux transporter or its emerging functions in magnesium homeostasis and disease contexts (Parkinson's disease genetic association, preeclampsia). The Knockout line is the standard tool for asking whether SLC41A1 is required for cellular magnesium extrusion — SLC41A1 functions as a Na⁺/Mg²⁺ exchanger at the plasma membrane. Overexpression is useful for testing transport activity in heterologous systems or for studying SLC41A1 in cancer contexts where altered magnesium homeostasis affects proliferation. For magnesium biology research, the EDITGENE SLC41A1 Knockout in HCT 116 enables study of cellular magnesium efflux and downstream Mg²⁺-dependent processes. Rescue with wild-type or transport-deficient SLC41A1 is the standard specificity control. Combined analysis with TRPM7 (the major Mg²⁺ uptake channel) and SLC41A2 paralog expression provides comprehensive Mg²⁺ homeostasis characterization.

Yes. SLC41A1 rescue experiments require attention to Mg²⁺ efflux mechanism: • Construct design: use a codon-modified SLC41A1 sequence with a small C-terminal tag (FLAG, HA). SLC41A1 has 10 transmembrane domains — N-terminal tags must not disrupt topology. • Transport-deficient rescue: conserved residue mutations in the MgtE-related membrane domain enable structure-function studies. • Surface localization validation: SLC41A1 trafficks to the plasma membrane — confirm exogenous surface localization by cell surface biotinylation before functional assays. • Functional readout: rescue should restore cellular Mg²⁺ efflux measured by Mag-Fluo-4 imaging or ICP-MS. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC71A1 (MFSD14A/HIAT1)'s role as a Golgi-localized MFS-family transporter or its emerging functions in energy homeostasis and reproductive biology. Note that SLC71A1 is the current HGNC-approved symbol; this gene is widely referred to as MFSD14A or HIAT1 (hippocampus abundant transcript 1) in published literature. It shows sequence and structural homology with sugar transporters — including the GLUT2/GLUT4 glucose transporters and bacterial tetracycline resistance proteins — possessing the characteristic 12-transmembrane α-helical architecture and the P-E-S-P-R motif found in facilitative glucose transporters, although its physiological substrate remains uncharacterized. The Knockout line is appropriate for asking whether SLC71A1 is required for cellular phenotypes connected to its established biology — published Mfsd14a/Hiat1 knockout mice show globozoospermia and male infertility (Spermatogenic Failure 19), and nutrient-availability studies have shown SLC71A1 expression changes with amino acid starvation and feeding state. Overexpression in HCT 116 may inform on substrate identification and trafficking. For physiological function research, particularly reproductive biology, germ-cell models are more appropriate; for energy homeostasis, neuronal or hepatic models complement the HCT 116 background. Rescue with wild-type SLC71A1 is the standard specificity control.

Yes. SLC71A1 rescue experiments require attention to MFS family transporter architecture: • Construct design: use a codon-modified SLC71A1 sequence with a small C-terminal tag (FLAG, HA). SLC71A1/MFSD14A is a 490-amino-acid MFS transporter with 12 predicted transmembrane domains — N-terminal tags must not disrupt membrane topology. • Golgi localization validation: confirm Golgi targeting of exogenous SLC71A1 by Giantin co-staining before functional assays; published evidence indicates Golgi rather than plasma membrane localization in neurons. • Transport-deficient rescue: mutations in conserved MFS family residues (e.g., the D-R/K-X-G-R-R/K motif between TM2 and TM3, or the P-E-S-P-R motif at the end of TM6) enable distinguishing transport activity from non-transport functions. • Disease variant rescue: introduction of Spermatogenic Failure 19-associated mutations enables genotype-function correlation studies in a controlled HCT 116 background. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation; the colorectal cancer background is appropriate for biochemical mechanism studies and substrate discovery experiments.

The choice depends on whether you are studying SLC6A17's role as a brain-specific neutral amino acid transporter or its emerging functions in intellectual disability genetics. The Knockout line is appropriate for asking whether SLC6A17 is required for neutral amino acid transport in non-neuronal contexts. Note that SLC6A17 is predominantly expressed in brain (synaptic vesicles in glutamatergic neurons) — HCT 116 expresses minimal endogenous SLC6A17, making this model most useful for biochemical and inhibitor studies. For physiologically relevant SLC6A17 research — particularly intellectual disability modeling — neuronal cell systems are more appropriate. The EDITGENE Knockout in HCT 116 is useful for confirming complete loss in cells with low baseline expression, for heterologous expression studies, and for autosomal recessive intellectual disability disease variant rescue experiments in a controlled background.

Yes. SLC6A17 rescue experiments have specific considerations for a brain-specific transporter: • Construct design: use a codon-modified SLC6A17 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane SLC6 architecture and SLC6A17's vesicular targeting signals must be preserved. • Heterologous expression context: HCT 116 is not the physiological cellular context for SLC6A17 — rescue is effectively a controlled heterologous expression study, useful for biochemical and disease variant characterization. • Disease mutation rescue: autosomal recessive intellectual disability-associated SLC6A17 variants enable genotype-function studies in a tractable cellular background. • Functional readout: rescue should restore neutral amino acid transport activity measured by uptake assays. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation. For physiological function studies, neuronal models are more appropriate.

The choice depends on whether you are studying SLC39A4 (ZIP4)'s role in intestinal zinc absorption or modeling acrodermatitis enteropathica. The Knockout line is the standard tool for asking whether ZIP4 is required for cellular zinc uptake — ZIP4 is the principal apical zinc transporter in intestinal epithelium and is essential for systemic zinc homeostasis. Overexpression is useful for testing whether elevated ZIP4 enhances zinc uptake or for studying cancer-associated ZIP4 upregulation (pancreatic cancer, others). For ZIP4 research, the EDITGENE Knockout in HCT 116 is particularly relevant for intestinal zinc absorption biology in a colorectal cancer-derived background. SLC39A4 mutations cause acrodermatitis enteropathica (autosomal recessive zinc deficiency syndrome) — disease variant rescue enables genotype-function correlation studies. Rescue with wild-type or transport-deficient ZIP4 is the standard specificity control.

Yes. ZIP4 rescue experiments are well-established for zinc biology research: • Construct design: use a codon-modified SLC39A4 sequence with a small C-terminal tag (FLAG, HA). ZIP4 has 8 transmembrane domains and an N-terminal extracellular ectodomain — preserve both elements. • Disease mutation rescue: acrodermatitis enteropathica-associated SLC39A4 mutations (e.g., G643R, P200L) enable disease genotype-function studies. • Surface localization validation: confirm plasma membrane localization of exogenous ZIP4 by cell surface staining before zinc uptake assays. • Functional readout: rescue should restore zinc uptake activity measured by FluoZin-3 imaging or ⁶⁵Zn uptake. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.